Settings

Applicant intake

Pull applicants from every source into one queue, without changing how you already collect them.

Intake carries patient info (PHI). Addresses and imported lists are scoped to your team only. Never share an intake address publicly.
NCT05788536 · A Study of DB-OTO, an Adeno-Associated Virus (AAV) Based Gene Therapy,
in-4157ee4cc934@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT05539716 · Metabolism and Sleep Apnea Treatment
in-2fe89e1efa19@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT05287867 · Trial for Treating Painful Degenerative Disc Disease
in-4bde2f5ea7fc@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT07674654 · Elismetrep (K-304) Long-Term Safety in Acute Migraine
in-5e4900831d53@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT07645924 · Elismetrep (K-304) for the Acute Treatment of Migraine
in-1d6a27c46b88@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT07573176 · Seltorexant Monotherapy in Major Depressive Disorder
in-5973086d97ec@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT07076407 · Azetukalner vs Placebo in Major Depressive Disorder (X-NOVA3)
in-f9e68d5d6a84@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT06922110 · Azetukalner Open-Label Extension in Major Depressive Disorder (X-NOVA-
in-ee1b64f54740@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT06559306 · Adjunctive Seltorexant in MDD With Insomnia Symptoms
in-440e3af7810c@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT06417775 · Ubrogepant for Menstrual Migraine
in-d936c5919757@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.

NCT05711940 · COMP360 Psilocybin in Treatment-Resistant Depression
in-e089c7d722c1@intake.bridgemd.com

Forward your recruitment inbox (or set an auto-forward) to this address. Every email becomes an applicant in this study's queue, de-duplicated and pre-screened.